Gm Collin Puracne

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the treatment of acne vulgaris. It helps to dry and clear existing acne pimples and is effective in preventing the formation of new acne pimples.

Dosage and Administration

Healthcare professionals are advised to follow the outlined procedures for the application of this product to ensure optimal results and minimize adverse reactions.

Prior to application, it is essential to wash hands thoroughly with a non-medicinal soap. The skin should be cleaned meticulously using the appropriate G.M. Collin cleanser to prepare the area for treatment.

For new users, it is recommended to apply the product to a small area once daily for three consecutive days to assess sensitivity to the formulation. Following this initial testing phase, the product may be applied to the affected areas in the morning and/or evening, or as directed by a skin care professional.

The initial application should consist of one application per day. Based on individual tolerance and response, the frequency may be increased as necessary. In cases where bothersome dryness or peeling occurs, it is advisable to reduce the application frequency to once daily or every other day to mitigate these effects.

Contraindications

Use is contraindicated in patients with very sensitive skin due to the potential for adverse reactions.

Warnings and Precautions

For external use only. This product is contraindicated in individuals with very sensitive skin.

General precautions should be observed to ensure safe use. It is imperative to avoid contact with the eyes, lips, and mouth. In the event of contact, the affected area should be rinsed thoroughly with water. Concurrent use of other topical acne medications may exacerbate skin dryness or irritation; therefore, it is advisable to use only one product at a time unless otherwise directed by a healthcare professional.

Users should be aware that this product may induce skin reactions, including irritation, burning, itching, swelling, and blistering. Should any of these symptoms manifest, it is essential to discontinue use immediately.

Patients are advised to stop use and consult a healthcare provider if the skin reaction becomes severe or extends beyond the application site. Additionally, if severe itching, hives, swelling of the eyes or mouth, blistering, or difficulty breathing occurs, immediate medical attention is warranted. If no substantial improvement is observed within 6 to 8 weeks of use, it is recommended to seek further medical advice.

In case of accidental ingestion, it is critical to seek emergency medical assistance or contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware that it is for external use only. It is contraindicated for individuals with very sensitive skin. During use, patients are advised to avoid contact with the eyes, lips, and mouth; in the event of contact, thorough rinsing with water is recommended.

Skin reactions are the most commonly reported adverse effects associated with this product. These may include irritation, burning, itching, swelling, and blistering of the skin. Should any of these symptoms occur, patients are instructed to discontinue use immediately.

In cases where skin reactions become severe or spread beyond the site of application, or if patients experience severe itching, hives, swelling of the eyes or mouth, blistering, or difficulty breathing, they should stop using the product and seek medical advice. Additionally, if no substantial improvement is observed within 6 to 8 weeks of use, patients are encouraged to consult a healthcare professional.

It is important to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is necessary. Caution is advised when using this product in conjunction with other topical acne medications, as this may exacerbate dryness or irritation of the skin; therefore, only one product should be used at a time unless otherwise directed by a healthcare provider.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Gm Collin Puracne (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

For new users, it is advised to apply the product to a small area once daily for three days to assess for any sensitivity to the formulation.

Geriatric Use

There is no specific information regarding the use of GM COLLIN PURACNE (salicylic acid gel) in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this medication to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The product has not been specifically studied in relation to pregnancy, and there are no explicit warnings or precautions regarding its use during this period. Current data does not indicate any specific safety concerns related to pregnancy. Additionally, there are no dosage modifications recommended for pregnant individuals. As such, no special precautions regarding the use of this product during pregnancy are provided in the available information. Healthcare professionals should consider the absence of data when advising pregnant patients or women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants during the use of this product in lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product if they have very sensitive skin. It is important to counsel patients to stop using the product and consult a doctor if they experience any of the following: a severe skin reaction that spreads beyond the site of application, severe itching, hives, swelling of the eyes or mouth, blistering, or difficulty breathing. Additionally, patients should be advised to seek medical advice if they do not see substantial improvement within 6 to 8 weeks of use.

When using this product, patients should be cautioned to avoid contact with the eyes, lips, and mouth. In the event of contact, they should rinse the area thoroughly with water. It is also essential to inform patients that using other topical acne medications simultaneously or immediately after applying this product may increase skin dryness or irritation. If such symptoms occur, patients should use only one product unless otherwise directed by a healthcare provider.

Patients should be made aware that this product may cause irritation, burning, itching, swelling, and blistering of the skin. They should discontinue use and consult a healthcare provider if any of these symptoms occur.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 15-30°C (59-86°F) to maintain its integrity and efficacy. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature limits to prevent degradation.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients to avoid contact with the eyes, lips, and mouth; in the event of contact, thorough rinsing with water is recommended. Patients should be advised that using other topical acne treatments concurrently or immediately after applying this product may exacerbate skin dryness or irritation. If such effects occur, it is advisable to limit the use to one product unless otherwise directed by a healthcare professional. Should bothersome dryness or peeling arise, patients may reduce the frequency of application to once daily or every other day.

Drug Information (PDF)

This file contains official product information for Gm Collin Puracne, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)